黄山胶囊(002817) - 2021 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2021 was ¥104,095,453.39, representing a 48.14% increase compared to ¥70,266,086.21 in the same period last year[7]. - The net profit attributable to shareholders was ¥10,799,475.10, up 19.76% from ¥9,017,259.94 year-on-year[7]. - The net profit after deducting non-recurring gains and losses was ¥8,727,524.14, reflecting a 16.93% increase from ¥7,463,846.01 in the previous year[7]. - The company reported a net profit margin improvement, with undistributed profits rising to CNY 341,651,516.17 from CNY 330,852,041.07, an increase of about 3.5%[47]. - Total comprehensive income for the first quarter was CNY 10,261,941.56, compared to CNY 8,704,549.13, marking an increase of approximately 17.9%[55]. - Operating profit for the first quarter was CNY 11,590,470.33, compared to CNY 10,316,722.66 in the previous period, showing an increase of about 12.3%[54]. - Net profit for the first quarter reached CNY 10,244,482.70, up from CNY 8,704,549.13, indicating a growth of approximately 17.7% year-over-year[54]. Cash Flow - The net cash flow from operating activities decreased by 33.52% to ¥14,824,838.69 from ¥22,298,376.00 in the same period last year[7]. - Net cash flow from operating activities decreased by CNY 7,473,500, a decline of 33.52% year-on-year, mainly due to increased cash payments for goods and services[30]. - Net cash flow from investing activities decreased by CNY 22,639,300, a decline of 164.54% year-on-year, primarily due to increased cash payments for the purchase of fixed assets, intangible assets, and other long-term assets[30]. - Net cash flow from financing activities increased by CNY 26,345,900, a growth rate of 48,972.63% year-on-year, mainly due to an increase in borrowings[30]. - The net increase in cash and cash equivalents decreased by CNY 3,756,200, a decline of 44.26% year-on-year, primarily due to reduced net cash flow from operating and investing activities despite increased financing cash flow[30]. - Cash inflow from operating activities amounted to CNY 78,514,426.76, an increase from CNY 60,921,525.98 in the previous period, reflecting a growth of approximately 28.8%[61]. - Cash outflow for the acquisition of fixed assets was CNY 36,355,474.13, compared to CNY 9,849,680.39 in the previous period, indicating increased capital expenditures[66]. Assets and Liabilities - Total assets at the end of the reporting period were ¥973,707,066.87, a 6.32% increase from ¥915,812,091.29 at the end of the previous year[7]. - The company's total liabilities reached CNY 198,295,383.55, compared to CNY 150,662,349.53 in the previous period, marking an increase of about 31.6%[46]. - Total liabilities increased by 325.80% to ¥651,600.00, mainly due to an increase in short-term borrowings[20]. - Non-current liabilities increased to CNY 56,778,836.53 from CNY 35,921,906.76, reflecting a rise of approximately 58%[50]. - Long-term borrowings increased significantly to CNY 33,991,846.98 from CNY 13,864,052.92, representing an increase of approximately 145%[50]. - The company's equity attributable to shareholders reached CNY 772,520,791.70, compared to CNY 761,707,349.51 in the previous period, reflecting a growth of about 1.1%[47]. Operational Costs and Expenses - The company reported a 71.43% increase in operating costs, amounting to ¥7,628,000.00, primarily due to increased sales and the inclusion of shipping costs in operating expenses[22]. - The company experienced a 506.82% increase in taxes and surcharges, totaling ¥626,000.00, due to the expiration of tax relief policies from the previous year[23]. - The company incurred a tax expense of CNY 1,337,857.63, slightly down from CNY 1,379,726.97 in the previous period[54]. - The company's R&D expenses increased by 35.37% to ¥341,130.00, driven by increased investment in R&D projects[24]. - Research and development expenses increased to CNY 3,602,953.61 from CNY 2,661,619.82, reflecting a rise of about 35.3%[53]. Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 14,546, with the largest shareholder holding 38.05% of the shares[11]. - Basic and diluted earnings per share were both CNY 0.07, an increase from CNY 0.06 in the same period last year[55].